HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).

Clinical immunology (Orlando, Fla.)
2005
https://researcherprofiles.org/profile/1446482
16257267
Vacek MM, Schäffer AA, Davis J, Fischer RE, Dale JK, Adams S, Straus SE, Puck JM